ArticleJournal of endocrinological investigation2025

Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.

F Coperchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.